If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Regulatory News (POLX)

Share Price Information for polarean (POLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.05
Bid: 4.00
Ask: 4.10
Change: 0.60 (17.39%)
Spread: 0.10 (2.50%)
Open: 3.50
High: 4.75
Low: 4.05
Prev. Close: 3.45
POLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

21 Aug 2023 17:29

RNS Number : 9825J
Polarean Imaging PLC
21 August 2023
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00Bf3DT583

Issuer Name

POLAREAN IMAGING PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

NUKEM Isotopes GmbH

City of registered office (if applicable)

Alzenau

Country of registered office (if applicable)

Germany

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

16-Aug-2023

6. Date on which Issuer notified

17-Aug-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

6.057000

0.000000

6.057000

13073462

Position of previous notification (if applicable)

5.525000

5.525000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BF3DT583

11523462

1550000

5.339000

0.718000

Sub Total 8.A

13073462

6.057000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

21-Aug-2023

13. Place Of Completion

Alzenau, Germany

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUAUNROOUWUAR
Date   Source Headline
30th Jul 20193:18 pmRNSHolding(s) in Company
30th Jul 20192:25 pmRNSHolding(s) in Company
29th Jul 20195:31 pmRNSHolding(s) in Company
25th Jul 20193:31 pmRNSResult of AGM
24th Jul 20192:45 pmRNSExercise of Warrants
22nd Jul 201910:00 amRNSPlacing to raise £2.1 million
11th Jul 20197:00 amRNSNew System Order
27th Jun 20197:00 amRNSFinal Results
13th Jun 20195:02 pmRNSInvestor Symposium presentations available online
11th Jun 20197:00 amRNSPhase III Clinical Trials - Update
5th Jun 20197:00 amRNSNew System Order
23rd May 20193:26 pmRNSGrant of Share Options
23rd May 20197:00 amRNSLondon Investor Symposium
21st May 20197:00 amRNS3rd tranche of $3m pediatric study grant confirmed
13th May 20197:00 amRNSClinical trial update
30th Apr 20197:00 amRNSTotal Voting Rights
29th Apr 20197:00 amRNSAppointment of Chief Financial Officer
2nd Apr 20197:00 amRNSExercise of Warrants
1st Apr 20197:00 amRNSAmphion Innovations - Pledge of Polarean shares
15th Feb 20197:00 amRNSNew System Order
24th Jan 20197:00 amRNSAppointment of Nominated Adviser and Broker
21st Jan 20193:36 pmRNSHolding(s) in Company
3rd Jan 20197:00 amRNSHolding(s) in Company
28th Dec 20182:52 pmRNSResult of General Meeting and Total Voting Rights
11th Dec 20187:05 amRNSInvestment in Polarean & Loan Facility Repayment
11th Dec 20187:00 amRNSConditional Fundraise to raise US$4 million
13th Nov 20187:00 amRNSLicencing Agreement with Duke University
6th Nov 20187:00 amRNSCompany update
5th Nov 20187:00 amRNSNominated Adviser Status
3rd Oct 20187:00 amRNSDelivery of Xenon Polariser
23rd Aug 20187:00 amRNSFIRST PATIENT IN PHASE III FDA CLINICAL TRIAL
22nd Aug 20187:00 amRNSHalf-year Report
27th Jul 20187:00 amRNSCompany update
18th Jul 20182:28 pmRNSResult of AGM
17th Jul 20182:49 pmRNSHolding(s) in Company
10th Jul 20183:22 pmRNSResult of Placing
9th Jul 20182:41 pmRNSProposed Placing to raise a minimum of £0.78m
21st Jun 201810:12 amRNSHolding(s) in Company
19th Jun 20184:40 pmRNSSecond Price Monitoring Extn
19th Jun 20184:35 pmRNSPrice Monitoring Extension
19th Jun 20187:00 amRNSInvestor Symposium
13th Jun 20187:00 amRNSFinal Results
6th Jun 20187:00 amRNSDelivery of Xenon Polariser
31st May 20187:00 amRNSLondon Investor Symposium
22nd May 20187:00 amRNSDelivery of Xenon Polariser
20th Apr 20187:00 amRNSGrant of Share Options
17th Apr 20187:00 amRNSPolarean technology used in severe asthma study
29th Mar 20187:00 amRNSAIM Admission & First Day of Dealings
29th Mar 20187:00 amRNSUpdate on Polarean Imaging IPO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.